Sonnet BioTherapeutics studies optimistic security outcomes from a section 1 trial of SON-1010 mixed with trabectedin for superior leiomyosarcoma or liposarcoma, with no...
The FDA authorized neoadjuvant Imfinzi, gemcitabine and cisplatin, adopted by adjuvant Imfinzi after radical cystectomy in muscle invasive bladder most cancers.The U.S. Meals...
For adults with PSMA+ metastatic castration-resistant prostate most cancers beforehand handled with androgen receptor inhibitors, the FDA expands Pluvicto indication.The U.S. Meals and...
